Trial Profile
Study of nebivolol and ramipril on biochemical parameters, arterial stiffness, and circadian profile of blood pressure (BP) in young men undergoing treatment for hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2018
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Ramipril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 13 Aug 2018 New trial record
- 01 Jul 2018 Results published in the Medicine